M&A considerations resulting from the new required tax treatment of R&D costs
New requirements to capitalize and amortize R&D costs are affecting M&A buyers by introducing costs and tax liabilities.
Workforce strategy: Tax considerations for a sustainable, effective plan
The tax planning and compliance considerations are often complex, so we have curated these insights to help foster your understanding.
SECURE 2.0’s legislative impact on plan corrections
SECURE 2.0 expanded the Employee Plans Compliance Resolution System (EPCRS) to enhance the operational feasibility of qualified plans.
FAQ: Capitalization and amortization of R&D costs under new section 174 rules
See how the new required tax treatment of R&D costs under section 174 affects federal, state, and international taxes, as…
Interest rates pose challenges for builders, but opportunities are on the horizon
Residential construction sees a favorable long-term outlook despite ongoing challenges affecting the housing market.
Trends and challenges facing middle market life sciences services companies
Life sciences services companies—like contract research organizations—experienced growth during the pandemic and are well positioned for opportunity.
Job openings and factory orders soften amid recession concerns
Job openings and factory orders came in lower than expected on Tuesday, continuing to show signs of softening economic demand…
The great deposit migration and emergency borrowing at the Fed discount window
In the past week alone, the Federal Reserve's loans outstanding to the financial system have ballooned to about $318 billion,…
5 critical components of your 2023 business strategy
In light of inflationary pressures, economic headwinds, geopolitical risk, and many conflicting so-called leading indicators, a business strategy refresh is…
Preclinical biopharma Meet change head on in the lab and beyond
You are preparing to enter a new stage as you approach trials. You need to lay an appropriate and scalable…